Clearline Capital’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.79M Hold
12,235,239
0.76% 43
2025
Q4
$15.9M Buy
12,235,239
+2,522,712
+26% +$3.11M 1.2% 27
2025
Q3
$12.2M Buy
9,712,527
+8,855,361
+1,033% +$14M 1.06% 42
2025
Q2
$1.77M Sell
857,166
-202,745
-19% -$414K 0.16% 85
2025
Q1
$2.33M Sell
1,059,911
-750,572
-41% -$1.46M 0.24% 80
2024
Q4
$2.77M Sell
1,810,483
-416,029
-19% -$674K 0.37% 65
2024
Q3
$4.43M Buy
2,226,512
+731,246
+49% +$1.75M 0.39% 72
2024
Q2
$5.23M Sell
1,495,266
-1,280,938
-46% -$3.94M 0.46% 66
2024
Q1
$7.69M Sell
2,776,204
-3,292,350
-54% -$8.28M 0.76% 40
2023
Q4
$10.3M Sell
6,068,554
-81,288
-1% -$89.5K 1.15% 29
2023
Q3
$6.33M Buy
6,149,842
+3,483,858
+131% +$4.96M 0.63% 51
2023
Q2
$3.09M Buy
2,665,984
+576,692
+28% +$1.03M 0.4% 61
2023
Q1
$3.15M Buy
2,089,292
+1,064,510
+104% +$2.67M 0.48% 55
2022
Q4
$2.56M Buy
+1,024,782
New +$3.3M 0.46% 58
2020
Q2
Sell
-47,667
Closed -$560K 80
2020
Q1
$560K Buy
+47,667
New +$896K 0.26% 55
2019
Q3
Sell
-16,920
Closed -$315K 57
2019
Q2
$315K Sell
16,920
-22,416
-57% -$448K 0.15% 47
2019
Q1
$961K Hold
39,336
0.5% 33
2018
Q4
$1.02M Buy
39,336
+8,577
+28% +$236K 0.7% 44
2018
Q3
$974K Buy
+30,759
New +$1.15M 0.58% 39

Other funds holding HRTX